Modeling HLA associations with EBV-positive and -negative Hodgkin lymphoma suggests distinct mechanisms in disease pathogenesis

International Journal of Cancer

Volumn 137, Issue 5, 2015, Pages 1066-1075

  Johnson, Paul C D ^a   McAulay, Karen A ^b   Montgomery, Dorothy ^b   Lake, Annette ^b   Shield, Lesley ^b   Gallagher, Alice ^b   Little, Ann Margaret ^c   Shah, Anila ^d   Marsh, Steven G E ^d,e   Taylor, G Malcolm ^f   Jarrett, Ruth F ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b MRC UNIVERSITY OF GLASGOW CENTRE FOR VIRUS RESEARCH   (United Kingdom)

^c GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

^d ROYAL FREE HOSPITAL   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

EBV; HLA; Hodgkin lymphoma

Indexed keywords

HLA A ANTIGEN; HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA B ANTIGEN; HLA DPB1 ANTIGEN; HLA DRB1 ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; CARCINOGENESIS; CLASSICAL HODGKIN LYMPHOMA; CONTROLLED STUDY; EPSTEIN BARR VIRUS INFECTION; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPING TECHNIQUE; HLA A GENE; HLA B GENE; HLA DPB1 GENE; HLA DRB1 GENE; HLA TYPING; HUMAN; MAJOR CLINICAL STUDY; MALE; MONONUCLEOSIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; DISEASE PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HODGKIN DISEASE; MIDDLE AGED; PATHOLOGY; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; DISEASE SUSCEPTIBILITY; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-DRB1 CHAINS; HODGKIN DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 84931574777     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29467     Document Type: Article

References (47)

1. Kuppers R,. The biology of Hodgkin's lymphoma. Nat Rev Cancer 2009; 9: 15-27.
2. Bleyer A, Barr R,. Cancer in young adults 20 to 39 years of age: overview. Semin Oncol 2009; 36: 194-206.
3. Liu Y, Sattarzadeh A, Diepstra A, et al., The microenvironment in classical hodgkin lymphoma: an actively shaped and essential tumor component. Semin Cancer Biol 2014; 24: 15-22.
4. Jarrett RF., The role of viruses in the genesis of Hodgkin lymphoma. In:, Engert A, Horning SJ, eds. Hematologic Malignancies: Hodgkin Lymphoma. Heidelberg Dordrecht London New York: Springer, 2011. 21-32.
5. Jarrett RF, Krajewski AS, Angus B, et al., The Scotland and Newcastle epidemiological study of Hodgkin's disease: impact of histopathological review and EBV status on incidence estimates. J Clin Pathol 2003; 56: 811-6.
6. Hislop AD, Taylor GS, Sauce D, et al,. Cellular responses to viral infection in humans: lessons from Epstein-Barr virus. Annu Rev Immunol 2007; 25: 587-617.
7. Alexander FE, Jarrett RF, Lawrence D, et al., Risk factors for Hodgkin's disease by Epstein-Barr virus (EBV) status: prior infection by EBV and other agents. Br J Cancer 2000; 82: 1117-21.
8. Hjalgrim H, Askling J, Rostgaard K, et al., Characteristics of Hodgkin's lymphoma after infectious mononucleosis. N Engl J Med 2003; 349: 1324-32.
9. Alexander FE, Lawrence DJ, Freel J, et al., An epidemiologic study of index and family infectious mononucleosis and adult Hodgkin's disease (HD): evidence for a specific association with EBV+ve HD in young adults. Int J Cancer 2003; 107: 298-302.
10. Amiel J., Study of the leukocyte phenotypes in Hodgkin's disease. In:, Teraski PI, ed. Histocompatibility Testing. Copenhagen, Denmark: Munksgaard, 1967. 79-81.
11. Hors J, Dausset J,. HLA and susceptibility to Hodgkin's disease. Immunol Rev 1983; 70: 167-92.
12. Bodmer JG, Tonks S, Oza AM, et al., HLA-DP based resistance to Hodgkin's disease. Lancet 1989; 1: 1455-6.
13. Tonks S, Oza AM, Lister TA, et al,. Association of HLA-DPB with Hodgkin's disease. Lancet 1992; 340: 968-9.
14. Taylor GM, Gokhale DA, Crowther D, et al., Evidence of an increased frequency of HLA-DPB1 0301 in Hodgkin's disease supports an infectious aetiology. In:, Jarrett RF, ed. The Etiology of Hodgkin's Disease, 1 edn. London: Plenum, 1995. 15-25.
15. Taylor GM, Gokhale DA, Crowther D, et al., Increased frequency of HLA-DPB1∗0301 in Hodgkin's disease suggests that susceptibility is HVR-sequence and subtype-associated. Leukemia 1996; 10: 854-9.
16. Alexander FE, Jarrett RF, Cartwright RA, et al., Epstein-Barr virus and HLA-DPB1-∗0301 in young adult Hodgkin's disease: evidence for inherited susceptibility to Epstein-Barr virus in cases that are EBV(+ve). Cancer Epidemiol Biomarkers Prev 2001; 10: 705-9.
17. Klitz W, Aldrich CL, Fildes N, et al., Localization of predisposition to Hodgkin disease in the HLA class II region. Am J Hum Genet 1994; 54: 497-505.
18. Diepstra A, Niens M, Vellenga E, et al., Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma. Lancet 2005; 365: 2216-24.
19. Niens M, van den Berg A, Diepstra A, et al., The human leukocyte antigen class I region is associated with EBV-positive Hodgkin's lymphoma: HLA-A and HLA complex group 9 are putative candidate genes. Cancer Epidemiol Biomarkers Prev 2006; 15: 2280-4.
20. Niens M, Jarrett RF, Hepkema B, et al., HLA-A∗02 is associated with a reduced risk and HLA-A∗01 with an increased risk of developing EBV-positive Hodgkin lymphoma. Blood 2007; 110: 3310-5.
21. Hjalgrim H, Rostgaard K, Johnson PC, et al., HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma. Proc Natl Acad Sci USA 2010; 107: 6400-5.
22. Huang X, Kushekhar K, Nolte I, et al., HLA associations in classical Hodgkin lymphoma: EBV status matters. PLoS One 2012; 7: e39986
23. Enciso-Mora V, Broderick P, Ma Y, et al., A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3). Nat Genet 2010; 42: 1126-30.
24. Urayama KY, Jarrett RF, Hjalgrim H, et al., Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups. J Natl Cancer Inst 2012; 104: 240-53.
25. Cozen W, Li D, Best T, et al., A genome-wide meta-analysis of nodular sclerosing Hodgkin lymphoma identifies risk loci at 6p21.32. Blood 2012; 119: 469-75.
26. Frampton M, da Silva Filho MI, Broderick P, et al., Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin's lymphoma. Nat Commun 2013; 4: 2549
27. Moutsianas L, Enciso-Mora V, Ma YP, et al., Multiple Hodgkin lymphoma-associated loci within the HLA region at chromosome 6p21.3. Blood 2011; 118: 670-4.
28. Taylor GM, Dearden S, Payne N, et al., Evidence that an HLA-DQA1-DQB1 haplotype influences susceptibility to childhood common acute lymphoblastic leukaemia in boys provides further support for an infection-related aetiology. Br J Cancer 1998; 78: 561
29. Taylor GM, Gokhale DA, Crowther D, et al., Further investigation of the role of HLA-DPB1 in adult Hodgkin's disease (HD) suggests an influence on susceptibility to different HD subtypes. Br J Cancer 1999; 80: 1405-11.
30. Taylor GM, Dearden S, Ravetto P, et al., Genetic susceptibility to childhood common acute lymphoblastic leukaemia is associated with polymorphic peptide-binding pocket profiles in HLA-DPB1∗0201. Hum Mol Genet 2002; 11: 1585-97.
31. Gonzalez-Galarza FF, Christmas S, Middleton D, et al., Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations. Nucleic Acids Res 2011; 39: D913-D919.
32. Li J, Ji L,. Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity 2005; 95: 221-7.
33. Hurvich CM, Tsai CL,. Model selection for extended quasi-likelihood models in small samples. Biometrics 1995; 51: 1077-84.
34. Lee KE, Sha N, Dougherty ER, et al., Gene selection: a Bayesian variable selection approach. Bioinformatics 2003; 19: 90-7.
35. Stephens M, Balding DJ,. Bayesian statistical methods for genetic association studies. Nat Rev Genet 2009; 10: 681-90.
36. Firth D,. Bias reduction of maximum likelihood estimates. Biometrika 1993; 80: 27-38.
37. Stram DO, Leigh PC, Bretsky P, et al., Modeling and E-M estimation of haplotype-specific relative risks from genotype data for a case-control study of unrelated individuals. Hum Hered 2003; 55: 179-90.
38. Sinnwell JP, Schaid DJ., Haplo.stats: Statistical Analysis of Haplotypes with Traits and Covariates when Linkage Phase is Ambiguous. R package version 1 6 3. 2003. Available at: URL: http://CRAN.R-project.org/package=haplo.stats.
39. R Development Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing. Vienna, Austria: R Development Core Team. http://www r-projectorg/2012. Available at: URL: http://www.r-project.org/.
40. McAulay KA, Higgins CD, Macsween KF, et al., HLA class I polymorphisms are associated with development of infectious mononucleosis upon primary EBV infection. J Clin Invest 2007; 117: 3042-8.
41. Ramagopalan SV, Meier UC, Conacher M, et al., Role of the HLA system in the association between multiple sclerosis and infectious mononucleosis. Arch Neurol 2011; 68: 469-72.
42. Voo KS, Fu T, Wang HY, et al., Evidence for the presentation of major histocompatibility complex class I-restricted Epstein-Barr virus nuclear antigen 1 peptides to CD8+ T lymphocytes. J Exp Med 2004; 199: 459-70.
43. Bell MJ, Brennan R, Miles JJ, et al., Widespread sequence variation in Epstein-barr virus nuclear antigen 1 influences the antiviral T cell response. J Infect Dis 2008; 197: 1594-7.
44. Leen A, Meij P, Redchenko I, et al., Differential immunogenicity of Epstein-Barr virus latent-cycle proteins for human CD4(+) T-helper 1 responses. J Virol 2001; 75: 8649-59.
45. Westra HJ, Peters MJ, Esko T, et al., Systematic identification of trans eQTLs as putative drivers of known disease associations. Nat Genet 2013; 45: 1238-43.
46. Diepstra A, van Imhoff GW, Karim-Kos HE, et al., HLA class II expression by Hodgkin Reed-Sternberg cells is an independent prognostic factor in classical Hodgkin's lymphoma. J Clin Oncol 2007; 25: 3101-8.
47. Chen JJ,. The Hardy-Weinberg principle and its applications in modern population genetics. Front Biol 2010; 5: 348-53.